(VIANEWS) – The NASDAQ ended the session with Horizon Therapeutics jumping 6.24% to $88.46 on Tuesday, after four consecutive sessions in a row of losses. NASDAQ jumped 1.65% to $11,815.23, after three successive sessions in a row of losses, on what was an all-around positive trend trading session today.


Today’s last reported volume for Horizon Therapeutics is 1700350, 12.08% below its average volume of 1934120.

Horizon Therapeutics’s last close was $83.26, 30.93% under its 52-week high of $120.54.

Horizon Therapeutics’s Sales

Horizon Therapeutics’s sales growth is 34.1% for the ongoing quarter and 177.8% for the next. The company’s growth estimates for the present quarter and the next is 14.8% and 4300%, respectively.

Horizon Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 36.1%, now sitting on 3.23B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Horizon Therapeutics’s stock is considered to be overbought (>=80).

Horizon Therapeutics’s Stock Yearly Top and Bottom Value

Horizon Therapeutics’s stock is valued at $88.46 at 18:53 EST, way under its 52-week high of $120.54 and above its 52-week low of $83.42.

Horizon Therapeutics’s Moving Average

Horizon Therapeutics’s value is way below its 50-day moving average of $104.60 and way under its 200-day moving average of $104.49.

More news about Horizon Therapeutics (HZNP).


Please enter your comment!
Please enter your name here